MIRM - Mirum Pharmaceuticals - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.017B

Cash

330M

Avg Qtr Burn

-24.1M

Short % of Float

21.63%

Insider Ownership

4.17%

Institutional Own.

84.83%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
LIVMARLI (Maralixibat) Details Alagille syndrome, Chronic pruritus	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LIVMARLI (Maralixibat) Details Liver disease, Progressive familial intrahepatic cholestasis	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Chenodal® (chenodiol) Details Cerebrotendinous xanthomatosis	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Volixibat (VANTAGE) Details Primary biliary cholangitis, Liver disease	Phase 2b Interim update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Volixibat (VISTAS) Details Liver disease, Primary sclerosing cholangitis	Phase 2b Interim update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LIVMARLI (Maralixibat) Details Rare diseases, Bile duct disease Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Volixibat (OHANA) Details Liver disease, Intrahepatic Cholestasis of Pregnancy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.